Aditxt (NASDAQ:ADTX) Issues Earnings Results

Aditxt (NASDAQ:ADTX) posted its quarterly earnings data on Wednesday. The company reported $999.00 earnings per share (EPS) for the quarter, Zacks reports. Aditxt had a negative net margin of 1,217,927.00% and a negative return on equity of 374.60%.

Aditxt Stock Down 7.9%

NASDAQ ADTX traded down $0.12 during trading hours on Wednesday, reaching $1.40. 213,367 shares of the company were exchanged, compared to its average volume of 77,335. The stock has a market capitalization of $46,200.00, a P/E ratio of 0.00 and a beta of 1.08. The business’s 50 day simple moving average is $20.45 and its 200-day simple moving average is $285.05. Aditxt has a 1 year low of $1.34 and a 1 year high of $53,451.08.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aditxt has a consensus rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.